# Bicalutamide Therapy in Young Women With NAFLD and PCOS

> **NCT05979389** · PHASE1 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 50 (estimated)

## Conditions studied

- NAFLD
- PCOS

## Interventions

- **DRUG:** Bicalutamide 50 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05979389
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-14
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05979389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05979389, "Bicalutamide Therapy in Young Women With NAFLD and PCOS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05979389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*